No difference in biochemical failure rates with or without pelvic lymph node dissection during radical prostatectomy in low-risk patients

Urology

Volumn 56, Issue 1, 2000, Pages 92-95

  Fergany, Amr ^a   Kupelian, Patrick A ^a   Levin, Howard S ^a   Zippe, Craig D ^a   Reddy, Chandana ^a   Klein, Eric A ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CANCER GRADING; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; DISSECTION; FOLLOW UP; HUMAN; HUMAN TISSUE; LYMPHADENECTOMY; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PELVIS LYMPH NODE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATECTOMY; RELAPSE;

AGED; DISEASE-FREE SURVIVAL; FOLLOW-UP STUDIES; HUMANS; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; PELVIS; PROSTATECTOMY; PROSTATIC NEOPLASMS; RISK FACTORS; TREATMENT FAILURE;

EID: 0034051246     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-4295(00)00550-1     Document Type: Article

References (9)

1. Petros J.A., Catalona W.J. Lower incidence of unsuspected lymph node metastases in 521 consecutive patients with clinically localized prostate cancer. J Urol. 147:1992;1574-1575.
2. Danella J.F., deKernion J.B., Smith R.B., et al. The contemporary incidence of lymph node metastases in prostate cancer implications for laparoscopic lymph node dissection . J Urol. 149:1993;1488-1491.
3. Campbell S.C., Klein E.A., Levin H.S., et al. Open pelvic lymph node dissection for prostate cancer a reassessment . Urology. 46:1995;352-355.
4. Bluestein D.L., Bostwick D.G., Bergstralh E.J., et al. Eliminating the need for bilateral pelvic lymphadenectomy in select patients with prostate cancer. J Urol. 151:1994;1315-1320.
5. Narayan P., Fournier G., Gajendran V., et al. Utility of preoperative serum prostate-specific antigen concentration and biopsy Gleason score in predicting risk of pelvic lymph node metastases in prostate cancer. Urology. 44:1994;519-524.
6. Sullivan L.D., Rabbani F. Should we reconsider the indications for ileo-obturator node dissection with localized prostate cancer? Br J Urol. 75:1995;33-37.
7. Bishoff J.T., Reyes A., Thompson I.M., et al. Pelvic lymphadenectomy can be omitted in selected patients with carcinoma of the prostate development of a system of patient selection . Urology. 45:1995;270-274.
8. Partin A.W., Yoo J., Carter H.B., et al. The use of prostate specific antigen, clinical stage and Gleason score to predict pathological stage in men with localized prostate cancer. J Urol. 150:1993;110-114.
9. El-Galley R.E., Keane T.E., Petros J.A., et al. Evaluation of staging lymphadenectomy in prostate cancer. Urology. 52:1998;663-667.